Secondary myelodysplastic syndromes following treatment with azathioprine are associated with aberrations of chromosome 7.
Détails
ID Serval
serval:BIB_AC57CA72EBF5
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Secondary myelodysplastic syndromes following treatment with azathioprine are associated with aberrations of chromosome 7.
Périodique
Haematologica
ISSN
1592-8721 (Electronic)
ISSN-L
0390-6078
Statut éditorial
Publié
Date de publication
05/2005
Peer-reviewed
Oui
Volume
90
Numéro
5
Pages
691-693
Langue
anglais
Notes
Publication types: Letter ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Publication Status: ppublish
Résumé
We report 14 cases of secondary myelodysplastic syndromes (sMDS) following treatment with azathioprine for non-malignant disorders. Long-term treatment with azathioprine seems to be associated with an increased risk of MDS and subsequent leukemic transformation.
Mots-clé
Adult, Aged, Aged, 80 and over, Autoimmune Diseases/drug therapy, Azathioprine/adverse effects, Azathioprine/therapeutic use, Cell Transformation, Neoplastic/chemically induced, Chromosomes, Human, Pair 7/ultrastructure, Female, Heart Transplantation, Humans, Immunosuppressive Agents/adverse effects, Immunosuppressive Agents/therapeutic use, In Situ Hybridization, Fluorescence, Kidney Transplantation, Male, Middle Aged, Monosomy, Myelodysplastic Syndromes/chemically induced, Myelodysplastic Syndromes/genetics, Postoperative Complications/chemically induced, Retrospective Studies, Rheumatic Diseases/drug therapy, Translocation, Genetic
Pubmed
Web of science
Création de la notice
16/07/2019 12:37
Dernière modification de la notice
21/08/2019 5:37
Données d'usage
